Related Experiment Video

Updated: Feb 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth

J H Azambuja1, N E Gelsleichter1, L R Beckenkamp1

  • 1Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245-Prédio Principal-sala 304, CEP, Porto Alegre, RS, 90050-170, Brazil.

Molecular Neurobiology
|August 18, 2018
PubMed

Insights

CD73 enzyme inhibition significantly reduced glioblastoma growth and invasion by decreasing adenosine levels. This approach enhanced chemotherapy effectiveness and showed promise for brain tumor treatment without systemic toxicity.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Glioblastoma is an aggressive primary brain tumor.
  • CD73 enzyme produces adenosine (ADO), a molecule implicated in tumor progression.

Purpose of the Study:

  • To investigate the role of CD73 in glioblastoma progression.
  • To evaluate CD73 inhibition as a therapeutic strategy for glioblastoma.

Main Methods:

  • CD73 downregulation using siRNA or enzyme inhibition (APCP).
  • Assessment of glioma cell viability, migration, invasion, and proliferation.
  • Analysis of cell cycle, Akt/NF-kB pathways, and temozolomide (TMZ) sensitivity.
  • In vivo studies using rat glioblastoma models.

Main Results:

  • CD73 downregulation reduced glioma cell migration, invasion, and proliferation (40%).
  • CD73 inhibition potentiated temozolomide's cytotoxic effect and sensitized cells to non-cytotoxic drug concentrations.
  • In vivo, siRNA-CD73 and APCP reduced tumor size by 45% and 40%, respectively, with a 95% reduction in CSF ADO levels.
  • No systemic damage or mortality was observed.

Conclusions:

  • CD73 plays a crucial role in glioblastoma progression.
  • CD73 inhibition is a promising therapeutic target for glioblastoma.
  • Combined CD73 inhibition and chemotherapy may improve brain tumor treatment outcomes.
Keywords:
APCPAdenosineCD73GliomasiRNA

More Related Videos

Author Spotlight: Using the Chick Embryo Brain as a Model for In Vivo and Ex Vivo Analyses of Human Glioblastoma Cell Behavior07:53

Author Spotlight: Using the Chick Embryo Brain as a Model for In Vivo and Ex Vivo Analyses of Human Glioblastoma Cell Behavior

Published on: May 26, 2023

4.6K
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.4K

Related Concept Videos

Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
299
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
906
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
236
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.6K